Cui Chen
- Topics
- Lymphoma Diagnosis and Treatment (6 papers)Esophageal Cancer Research and Treatment (5 papers)Epigenetics and DNA Methylation (5 papers)
- Journals
- SHILAP Revista de lepidopterologíaPLoS ONEScientific Reports
- Partner nations
- ChinaUnited StatesSouth Africa
In The Last Decade
Cui Chen
47 papers receiving 765 citations
Peers
Comparison fields: 5 of 92
- Oncology 342
- Molecular Biology 251
- Cancer Research 187
- Surgery 166
- Pulmonary and Respiratory Medicine 125
Countries citing papers authored by Cui Chen
This map shows the geographic impact of Cui Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cui Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cui Chen more than expected).
Fields of papers citing papers by Cui Chen
This network shows the impact of papers produced by Cui Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cui Chen. The network helps show where Cui Chen may publish in the future.
Co-authorship network of co-authors of Cui Chen
This figure shows the co-authorship network connecting the top 25 collaborators of Cui Chen. A scholar is included among the top collaborators of Cui Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cui Chen. Cui Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 2 | |
| 5 | 3 | |
| 6 | 10 | |
| 7 | 1 | |
| 8 | Incidence, Predictors, and Prognosis of Coronary Slow-Flow and No-Reflow Phenomenon in Patients with Chronic Total Occlusion Who Underwent Percutaneous Coronary Intervention | 5 |
| 9 | Downregulation of RRM2 Attenuates Retroperitoneal Liposarcoma Progression via the Akt/mTOR/4EBP1 Pathway: Clinical, Biological, and Therapeutic Significance | 1 |
| 10 | Downregulation of TfR1 promotes progression of colorectal cancer via the JAK/STAT pathway | 4 |
| 11 | Silencing of Peroxiredoxin 1 Inhibits the Proliferation of Esophageal Cancer Cells and Promotes Apoptosis by Inhibiting the Activity of the PI3K/AKT Pathway | 4 |
| 12 | Pharmacokinetics and Safety of Esketamine in Chinese Patients Undergoing Painless Gastroscopy in Comparison with Ketamine: A Randomized, Open-Label Clinical Study | 13 |
| 13 | TERT copy gain predicts the outcome of high-dose interferon α-2b therapy in acral melanoma | 0 |
| 14 | Clinical significance of serum MCP-1 and VE-cadherin levels in patients with acute cerebral infarction. | 17 |
| 15 | 48 | |
| 16 | 27 | |
| 17 | 38 | |
| 18 | 51 | |
| 19 | 3 | |
| 20 | 13 |
About Cui Chen
Cui Chen is a scholar working on Otorhinolaryngology, Health Informatics and Cancer Research, having authored 51 papers that have together received 772 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (6 papers), Esophageal Cancer Research and Treatment (5 papers) and Epigenetics and DNA Methylation (5 papers). The work is most often cited by research in Otorhinolaryngology (80 citations), Oncology (342 citations) and Cancer Research (187 citations). Cui Chen has collaborated with scholars based in China, United States and South Africa. Frequent co-authors include Peng Sun, Hang Yang, Xin An, Wenqi Jiang, Xiwen Bi, Fei Zhang, Feng‐Hua Wang, Hui-Wen Weng, Sheng Ye and Yun Miao. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.